1391 related articles for article (PubMed ID: 31394177)
1. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
2. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Prognostic Value of microRNA-203 in Solid Tumors Based on a Meta-Analysis and the Cancer Genome Atlas (TCGA) Datasets.
Shao Y; Gu W; Ning Z; Song X; Pei H; Jiang J
Cell Physiol Biochem; 2017; 41(4):1468-1480. PubMed ID: 28351024
[TBL] [Abstract][Full Text] [Related]
4. Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis.
Chen JA; Yu Y; Xue C; Chen XL; Cui GY; Li J; Li KF; Ren ZG; Sun RR
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):321-331. PubMed ID: 30290990
[TBL] [Abstract][Full Text] [Related]
5. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-200 families and prognostic value in various carcinomas: A systematic review and meta-analysis.
Yin Y; Song WW; Wang Y; Zhao W; Wu J; Xu W
Aging Med (Milton); 2018 Jun; 1(1):39-45. PubMed ID: 31942478
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: A meta-analysis.
Shi M; Mu Y; Zhang H; Liu M; Wan J; Qin X; Li C
Medicine (Baltimore); 2018 Aug; 97(32):e11505. PubMed ID: 30095616
[TBL] [Abstract][Full Text] [Related]
8. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
[No Abstract] [Full Text] [Related]
9. Prognostic Role of the MicroRNA-200 Family in Various Carcinomas: A Systematic Review and Meta-Analysis.
Lee JS; Ahn YH; Won HS; Sun S; Kim YH; Ko YH
Biomed Res Int; 2017; 2017():1928021. PubMed ID: 28321402
[No Abstract] [Full Text] [Related]
10. Prognostic Value of microRNA-224 in Various Cancers: A Meta-analysis.
Zhang Y; Guo CC; Guan DH; Yang CH; Jiang YH
Arch Med Res; 2017 Jul; 48(5):472-482. PubMed ID: 29133193
[TBL] [Abstract][Full Text] [Related]
11. Correlation between miR-200 Family Overexpression and Cancer Prognosis.
Liu W; Zhang K; Wei P; Hu Y; Peng Y; Fang X; He G; Wu L; Chao M; Wang J
Dis Markers; 2018; 2018():6071826. PubMed ID: 30069274
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies.
Xu L; Zhang Y; Tang J; Wang P; Li L; Yan X; Zheng X; Ren S; Zhang M; Xu M
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):867-881. PubMed ID: 30602498
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.
Zhang Y; Li Y; Jiang W; Li Q; Lan Y
Medicine (Baltimore); 2019 Mar; 98(13):e14810. PubMed ID: 30921182
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of microRNA-145 in patients with various cancers: a meta-analysis.
Dai SL; Zhou J; Pan C; Huang G; Shi ZL; Yang SY; Yang KX
Cancer Biomark; 2015; 15(4):507-13. PubMed ID: 25792469
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.
Gao S; Zhao ZY; Zhang ZY; Zhang Y; Wu R
Clin Transl Gastroenterol; 2018 Nov; 9(11):203. PubMed ID: 30420592
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Role of MicroRNA-126 for Survival in Malignant Tumors: A Systematic Review and Meta-Analysis.
Bu J; Li H; Li XY; Liu LH; Sun W; Xiao T
Dis Markers; 2015; 2015():739469. PubMed ID: 26351404
[TBL] [Abstract][Full Text] [Related]
17. MiR-200 family and cancer: From a meta-analysis view.
Huang GL; Sun J; Lu Y; Liu Y; Cao H; Zhang H; Calin GA
Mol Aspects Med; 2019 Dec; 70():57-71. PubMed ID: 31558294
[TBL] [Abstract][Full Text] [Related]
18. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA.
Ye B; Shi J; Kang H; Oyebamiji O; Hill D; Yu H; Ness S; Ye F; Ping J; He J; Edwards J; Zhao YY; Guo Y
RNA Biol; 2020 Nov; 17(11):1666-1673. PubMed ID: 31607216
[TBL] [Abstract][Full Text] [Related]
19. MiR-20a, a novel promising biomarker to predict prognosis in human cancer: a meta-analysis.
Huang D; Peng Y; Ma K; Deng X; Tang L; Jing D; Shao Z
BMC Cancer; 2018 Nov; 18(1):1189. PubMed ID: 30497428
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of miR-222 in Various Cancers: a Systematic Review and Meta-Analysis.
Wei T; Ye P; Peng X; Wu LL; Yu GY
Clin Lab; 2016 Aug; 62(8):1387-1395. PubMed ID: 28164621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
